Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 13

    1.

    Reply to A. Vazquez-Martin et al.

    Goodwin PJ, Ligibel JA, Stambolic V.

    J Clin Oncol. 2009 Nov 20;27(33):e210. Epub 2009 Oct 26. No abstract available. PMID: 19858374 [PubMed - as supplied by publisher]Related articles

    2.

    Reply to R. Memmott et al.

    Goodwin PJ, Ligibel JA, Stambolic V.

    J Clin Oncol. 2009 Oct 26. [Epub ahead of print] No abstract available. PMID: 19858365 [PubMed - as supplied by publisher]Related articles

    3.

    Could modification of lifestyle factors prevent second primary breast cancers?

    Ligibel JA.

    J Clin Oncol. 2009 Nov 10;27(32):5301-2. Epub 2009 Sep 8. No abstract available. PMID: 19738104 [PubMed - in process]Related articles

    4.

    Metformin in breast cancer: time for action.

    Goodwin PJ, Ligibel JA, Stambolic V.

    J Clin Oncol. 2009 Jul 10;27(20):3271-3. Epub 2009 Jun 1. No abstract available. PMID: 19487373 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors.

    Ligibel JA, Giobbie-Hurder A, Olenczuk D, Campbell N, Salinardi T, Winer EP, Mantzoros CS.

    Cancer Causes Control. 2009 May 13. [Epub ahead of print]PMID: 19434504 [PubMed - as supplied by publisher]Related articles

    6.

    Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.

    Ligibel JA, Partridge A, Giobbie-Hurder A, Golshan M, Emmons K, Winer EP.

    Ann Surg Oncol. 2009 Jan;16(1):106-12. Epub 2008 Oct 24.PMID: 18953612 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mucinous breast carcinoma: a large contemporary series.

    Barkley CR, Ligibel JA, Wong JS, Lipsitz S, Smith BL, Golshan M.

    Am J Surg. 2008 Oct;196(4):549-51.PMID: 18809061 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.

    Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP.

    J Clin Oncol. 2008 Feb 20;26(6):907-12.PMID: 18281663 [PubMed - indexed for MEDLINE]Related articles

    9.

    Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.

    Ligibel JA, Winer EP.

    Breast Cancer Res. 2005;7(6):255-7. Epub 2005 Nov 11. Review.PMID: 16457700 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer.

    Ligibel JA, Winer EP.

    Womens Health (Lond Engl). 2006 Jan;2(1):89-97.PMID: 19803930 [PubMed - in process]

    11.

    The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancer.

    Ligibel JA, Winer EP.

    J Natl Compr Canc Netw. 2003 Apr;1(2):215-21. Review.PMID: 19768880 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical differences among the aromatase inhibitors.

    Ligibel JA, Winer EP.

    Clin Cancer Res. 2003 Jan;9(1 Pt 2):473S-9S. Review.PMID: 12538503 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Trastuzumab/chemotherapy combinations in metastatic breast cancer.

    Ligibel JA, Winer EP.

    Semin Oncol. 2002 Jun;29(3 Suppl 11):38-43. Review.PMID: 12138396 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...